Dr. Shah on Results Seen With Brexucabtagene Autoleucel in Relapsed/Refractory B-ALL
June 11th 2021Bijal Shah, MD, MS, discusses the results seen with brexucabtagne autoleucel in patients with relapsed/refractory B-cell acute lymphoblastic leukemia, as demonstrated in the phase 2 ZUMA-3 trial.
Read More
Dr. Shah on Challenges of CAR T-Cell Clinical Trials in MCL
October 17th 2018Bijal D. Shah, MD, medical oncologist, Moffitt Cancer Center, assistant professor of oncology, University of South Florida, discusses the challenges of developing clinical trials for CAR T cells in mantle cell lymphoma.
Read More